NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
opolitan Police Department report that both tablet<br />
and powder methamphetamine are visible in the<br />
Washington, DC, club scenes. NFLIS data for Federal<br />
FY 2004 show that approximately 1 percent of<br />
analyzed drug items tested positive for methamphetamine.<br />
The NDIC reported that methamphetamine<br />
sold for $4,800 per one-half pound and 8-balls<br />
sold for $400 during the first 6 months of 2004.<br />
As in the District, the demand for and availability of<br />
methamphetamine in Maryland is extremely low<br />
compared to other drugs. Methamphetamine users in<br />
Maryland tend to be Caucasian males, particularly<br />
youth, those involved with the rave and club scenes,<br />
and middle- to lower-class blue collar workers.<br />
Methamphetamine use is more prevalent in the rural<br />
Western, Eastern, and Southern parts of the State.<br />
From January 2003 to May 2004, law enforcement<br />
officials reported that there were eight methamphetamine<br />
labs seized in Maryland: two in Garrett,<br />
one in Washington, three in Charles, one in Prince<br />
George's, and one in Cecil Counties.<br />
Although there is little indication that methamphetamine<br />
is an emerging problem in the District, there<br />
have been increases in the number of methamphetamine<br />
labs seized in several of the States surrounding<br />
the District. For example, there were 8 methamphetamine<br />
labs seized in Virginia in 1999, compared<br />
to 23 in 2003. In West Virginia and Pennsylvania, the<br />
number of labs seized over this period increased even<br />
more dramatically, from 3 to 52 and from 1 to 49,<br />
respectively.<br />
The Washington Post reported that nearly all of the<br />
methamphetamine seized in Virginia in 2004 was<br />
found in the Shenandoah Valley; methamphetamine<br />
is the primary drug seized along the north-south corridor<br />
between Winchester and Harrisonburg. A special<br />
report on methamphetamine from the Washington/Baltimore<br />
HIDTA explains this trend further. The<br />
cities of Harrisonburg and Strasburg, in particular,<br />
are highlighted by law enforcement as having a substantial<br />
methamphetamine presence. According to<br />
law enforcement, the primary users in these areas are<br />
rural, White, working-class adults, while the sellers<br />
are primarily Latino. Rival Hispanic criminal groups,<br />
such as MS-13 and South Side Locos in Strasburg,<br />
VA, have collaborated in the sale of methamphetamine<br />
since early 2004, increasing the chance that<br />
methamphetamine may increase in the area because<br />
of the presence of MS-13 in Maryland.<br />
Other Drugs<br />
Abuse of club drugs, such as MDMA, gamma hydroxybutyrate<br />
(GHB), and ketamine, is also relatively<br />
294<br />
<strong>EPIDEMIOLOGIC</strong> TRENDS IN <strong>DRUG</strong> <strong>ABUSE</strong>—Washington, DC<br />
low in the District. MDMA is the most readily available<br />
and frequently abused “club drug,” selling for<br />
$18–$25 per tablet in the fourth quarter of 2002, according<br />
to the DEA Washington Division. The Washington/Baltimore<br />
HIDTA estimated a slightly lower<br />
range for the cost per dosage unit: $10–$20. MDMA<br />
is most frequently used and distributed by teens and<br />
young adults at raves and nightclubs. MDMA is typically<br />
driven to the District from New York, Philadelphia,<br />
Orlando, and Miami by Dominican and Asian<br />
trafficking organizations.<br />
In the unweighted data accessed from DAWN Live!<br />
for 2004, there were 82 ED reports involving<br />
MDMA, 7 involving GHB, and 8 involving lysergic<br />
acid diethylamide (LSD) (exhibit 1b). There was only<br />
one report involving ketamine. MDMA and methylenedioxyamphetamine<br />
(MDA) each accounted for<br />
approximately 1 percent of analyzed drug items<br />
tested through NFLIS in Federal FY 2004. GHB and<br />
ketamine were each found in less than 1 percent of<br />
analyzed drug items tested through NFLIS in Federal<br />
FY 2004. No drug items tested positive for LSD. No<br />
deaths involving club drugs were reported in the<br />
DAWN mortality data from 1997 to 2002 (exhibit 2).<br />
Mentions of benzodiazepines are reported in the<br />
DAWN ED and mortality reports. In the unweighted<br />
DAWN data for 2004, 718 reports involved benzodiazepines.<br />
One death in 2001 was attributed solely to<br />
benzodiazepines (exhibit 2), but in the 1997–2000 time<br />
period, mentions of benzodiazepines in the mortality<br />
data ranged between 10 and 13. In 2002, four deaths<br />
were attributed to multiple drugs, including benzodiazepines.<br />
In the 2004 unweighted DAWN Live! system, there<br />
were 2,438 reports involving alcohol. DAWN mortality<br />
data show that mentions of deaths involving alcohol<br />
in combination with other drugs decreased from<br />
29 in 1997 to 17 in 2001, with a peak of 44 in 1998.<br />
In 2002, however, alcohol-involved deaths more than<br />
doubled to 37 deaths (exhibit 2). In 2003, primary<br />
alcohol admissions accounted for approximately 18<br />
percent of all treatment admissions, a slight decline<br />
from 2000 and 2001 (exhibit 3a).<br />
INFECTIOUS DISEASES RELATED TO <strong>DRUG</strong> <strong>ABUSE</strong><br />
The diagnosis of AIDS cases increased rapidly from<br />
1982 to 1993, when they peaked at 1,342 cases. The<br />
number of cases decreased 49 percent from 1993 to<br />
2001, but cases increased 37.5 percent in 2002. There<br />
were 943 diagnosed cases in 2002, the last year for<br />
which data are available (exhibit 7). Males accounted<br />
for 70 percent of cases diagnosed in 2002. Almost<br />
three-quarters of the diagnoses in 2002 occurred<br />
Proceedings of the Community Epidemiology Work Group, Vol. II, January 2005